Ovesco acquires Belgian-Luxemburg business from Fides Medical
Combining EFTR with other treatment modalities, such as snare polypectomy or pEMR, have recently been proposed to be useful for resection of large and complex colorectal tumors. In a current case series, Chua et al. reported on the treatment of colonic LSTs containing a small (< 20 mm) focus of submucosally invasive colorectal cancer (T1 CRC) using hybrid p-EMR-EFTR in a single session.
Tuebingen /Geetbets, 22.05.2023: Ovesco Endoscopy AG takes over the distribution of its products from its long-lasting distributor, Fides Medical BV by June 2023.
Fides Medical, led by Sandra Stam and Johan Ceuppens has been the commercial partner and exclusive distributor Of Ovesco in Belgium and Luxemburg since more than a decade. Fides now wants to consolidate its distribution business. Both companies have reached an agreement that Ovesco will acquire distribution and customer base from Fides and sell products directly in the territory from June 2023. Products can then be ordered directly through Ovesco’s customer service email@example.com or by phone 0032 (0)800 26221.
Marc Schurr, CEO of Ovesco, said, we are proud to be the successor of our long-standing distribution partner, Fides Medical in serving the hospital sector in Belgium and Luxemburg. Fides and the team around Sandra Stam and Johan Ceuppens have given us great representation for many years and we are very grateful for the starting position in making Belgium and Luxemburg direct markets for our company. Philipp Siebrecht, VP of Sales added, the transfer of Fides’ business to our direct sales network fits our strategy and we will strive at matching the high-quality service that the Fides team has given to hospitals in the area.
Sandra Stam and Johan Ceuppens, said, it was an honor and great pleasure to help developing the Ovesco project from the very beginning, since 2008. By transferring our Ovesco distribution in Belgium and Luxemburg to Ovesco, we trust that our customers will receive the best possible service and support. Ovesco and Fides will work closely together to ensure a smooth handover of distribution. We thank Marc and the entire Ovesco team for the pleasant and professional cooperation, and we wish them all the best in further developing the business in Belgium and Luxemburg.
Ovesco Endoscopy AG
Ovesco Endoscopy AG develops, manufactures and distributes instruments and systems for the treatment of gastrointestinal diseases. We offer comprehensive procedures and accompany our customers all the way from training to intervention.
As a research-based medical technology company, Ovesco is in constant collaboration with clinicians on new product ideas, studies, and the introduction of new procedures into physician education. The Ovesco team is fully committed to bringing products of outstanding quality and exceptional medical value to the clinic. We are fully committed to fulfilling our corporate responsibility to our environment. This includes supporting social diversity, humanitarian aid and improving the work-life balance.